Dendreon Corp $1.36

down 0.00


28/8/2014 04:00 PM  |  NASDAQ : DNDN  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get DNDN Trend Analysis - it has underperformed the S&P 500 by 73%

Partner Headlines

  1. A Few Reasons Why Investors Should Consider Dendreon for Their Portfolio

    GuruFocus
  2. Morning Market Losers

    Benzinga
  3. Dendreon's Debt Problem: Mulls Wiping Out Shareholders

    Benzinga
  4. Morning Market Movers

    Benzinga
  5. Benzinga's Top #PreMarket Gainers

    Benzinga
  6. Benzinga's Top #PreMarket Gainers

    Benzinga
  7. Cantor Weighs In On Dendreon Leadership Change

    Benzinga
  8. Morning Market Losers

    Benzinga
  9. Mid-Morning Market Update: Markets Gain; Johnson & Johnson Profit Beats ...

    Benzinga
  10. Dendreon Says Prelim. Data from LT Phase II STAND Study Will Be Presented ...

    Benzinga
  11. Short Interest Rises As Biotechs Fall (AMGN, CELG, DNDN)

    Benzinga
  12. Mid-Afternoon Market Update: Markets Rally on Easing Ukraine Tensions as ...

    Benzinga
  13. Morning Losers for Mar. 4, 2014: RSH, MDR, WBMD, CLF, DNDN

    Benzinga
  14. Benzinga's Top Downgrades

    Benzinga
  15. Mid-Day Market Update: Akorn Shares Slip After Downbeat Outlook; Dendreon ...

    Benzinga
  16. Mid-Morning Market Update: Markets Open Lower; Tyco To Sell South Korean ...

    Benzinga
  17. Morning Gainers for Mar. 3, 2014: DNDN, PERI, RVNC, ARRY, OMEX, NIHD

    Benzinga
  18. Morning Market Movers

    Benzinga
  19. Benzinga's Top #PreMarket Gainers

    Benzinga
  20. Earnings Scheduled For March 3, 2014

    Benzinga
  21. Mid-Afternoon Market Update: Markets Recovering Towards the End of the ...

    Benzinga
  22. Celgene, Dendreon Lead Short Interest Trend In Biotechs (BMRN, CELG, DNDN)

    Benzinga
  23. Gilead Sciences Leads In Rising Short Interest Among Biotechs

    Benzinga
  24. Earnings Expectations For The Week Of November 11: Walmart And Other Retailers

    Benzinga
  25. UPDATE: Maxim Upgraded Dendreon, Raises High PT

    Benzinga
  26. Benzinga's Top #PreMarket Gainers

    Benzinga
  27. Benzinga's Weekend M&A Chatter

    Benzinga
  28. Short Sellers Retreat From Biogen Idec, Move On Pharmacyclics (BIIB, BMRN, ...

    Benzinga
  29. Short Sellers Move On Amgen, Vertex (AMGN, PCYC, VRTX)

    Benzinga
  30. Dendreon Reports Presentation of PROVENGE® Data at '13 European Cancer ...

    Benzinga
  31. BioMarin, Celgene Lead Trend in Biotech Short Interest (BRMN, CELG, REGN)

    Benzinga
  32. Dendreon Reports Marketing Authorization for Provenge in EU

    Benzinga
  33. Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, CELG, ...

    Benzinga
  34. RBC Sets Likelihoods For Dendreon Sale Possibilities Moving Forward, Cuts ...

    Benzinga
  35. Short Interest In Celgene, Onyx Continues To Shrink (CELG, ONXX, VRTX)

    Benzinga
  36. Stocks Hitting 52-Week Lows

    Benzinga
  37. UPDATE: Deutsche Bank Downgrades Dendreon on Approaching Headwinds

    Benzinga
  38. Stocks Hitting 52-Week Lows

    Benzinga
  39. Benzinga's Top Pre-Market Losers

    Benzinga
  40. Benzinga's Top Downgrades

    Benzinga
  41. An Ocean of 52-Week Lows - 50% Off High, Second Quarter Financials

    GuruFocus
  42. Mid-Afternoon Market Update: Markets All Red as Dendreon Continues to Fall

    Benzinga
  43. Mid-Day Market Update: Markets Fall Sharply, Priceline Surges On Earnings ...

    Benzinga
  44. Mid-Morning Market Update: Markets Edge Lower, Lions Gate Reports Q1 Profit

    Benzinga
  45. Benzinga's Top Pre-Market Losers

    Benzinga
  46. Price Target on Dendreon Slashed from $1 to $0 at Wedbush, Says Expecting ...

    Benzinga
  47. Benzinga's Top Pre-Market Gainers

    Benzinga
  48. Mid-Afternoon Market Update: Dendreon Skyrockets as The Markets Trade in ...

    Benzinga
  49. Short Interest in Pharmacyclics Plunges (AMGN, ONXX, PCYC)

    Benzinga
  50. Analyst Downgrades: Dendreon Corporation, Weight Watchers, and Whole Foods ...

    SchaeffersResearch
Trading Center